aXichem AB (ST:AXIC-A) — Market Cap & Net Worth
Market Cap & Net Worth: aXichem AB (AXIC-A)
aXichem AB (ST:AXIC-A) has a market capitalization of $8.21 Million (Skr76.26 Million) as of June 16, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #27543 globally and #610 in its home market, demonstrating a -5.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying aXichem AB's stock price Skr1.29 by its total outstanding shares 59114905 (59.11 Million). Review aXichem AB (AXIC-A) total liabilities to assess the company's total debt and financial obligations.
aXichem AB Market Cap History: 2015 to 2026
aXichem AB's market capitalization history from 2015 to 2026. Data shows change from $33.41 Million to $8.21 Million (-12.20% CAGR).
aXichem AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how aXichem AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.01x
aXichem AB's market cap is 1.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $460.81 Million | $344.00K | -$9.93 Million | 1339.56x | N/A |
| 2019 | $536.93 Million | $343.00K | -$12.44 Million | 1565.39x | N/A |
| 2020 | $311.09 Million | $1.23 Million | -$13.52 Million | 253.54x | N/A |
| 2021 | $156.50 Million | $4.36 Million | -$15.09 Million | 35.88x | N/A |
| 2022 | $88.11 Million | $5.01 Million | -$17.26 Million | 17.60x | N/A |
| 2023 | $25.51 Million | $1.81 Million | -$20.81 Million | 14.10x | N/A |
| 2024 | $8.62 Million | $8.57 Million | -$17.81 Million | 1.01x | N/A |
Competitor Companies of AXIC-A by Market Capitalization
Companies near aXichem AB in the global market cap rankings as of June 16, 2026.
Key companies related to aXichem AB by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #95 globally with a market cap of $210.18 Billion USD.
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #243 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Air Liquide SA (PA:AI): Ranked #253 globally with a market cap of $101.06 Billion USD ( €86.44 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #333 globally with a market cap of $79.39 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #95 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $521.48 |
| #243 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #253 | Air Liquide SA | PA:AI | $101.06 Billion | €165.86 |
| #333 | Sherwin-Williams Co | NYSE:SHW | $79.39 Billion | $320.24 |
aXichem AB Historical Marketcap From 2015 to 2026
Between 2015 and today, aXichem AB's market cap moved from $33.41 Million to $ 8.21 Million, with a yearly change of -12.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr8.21 Million | -37.68% |
| 2025 | Skr13.17 Million | +52.77% |
| 2024 | Skr8.62 Million | -66.21% |
| 2023 | Skr25.51 Million | -71.05% |
| 2022 | Skr88.11 Million | -43.70% |
| 2021 | Skr156.50 Million | -49.69% |
| 2020 | Skr311.09 Million | -42.06% |
| 2019 | Skr536.93 Million | +16.52% |
| 2018 | Skr460.81 Million | +298.91% |
| 2017 | Skr115.52 Million | +245.28% |
| 2016 | Skr33.46 Million | +0.14% |
| 2015 | Skr33.41 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of aXichem AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.21 Million USD |
| MoneyControl | $8.21 Million USD |
| MarketWatch | $8.21 Million USD |
| marketcap.company | $8.21 Million USD |
| Reuters | $8.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About aXichem AB
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings a… Read more